Advertisement

Gynäkologische Endokrinologie

, Volume 16, Issue 2, pp 103–114 | Cite as

Pubertas tarda bei hypogonadotropem Hypogonadismus

Abklärung, Betreuung, späterer Kinderwunsch
  • M. Birkhäuser
Leitthema
  • 56 Downloads

Zusammenfassung

Die Pubertät leitet von der Kindheit ins Erwachsenenalter über. Die Hypothalamus-Hypophysen-Gonaden-Achse ist während der fetalen und neonatalen Entwicklung aktiviert und fällt danach bis zur Pubertät in eine Ruhephase. Die Pubertät beginnt mit einer Reaktivierung der gonadalen Achse. Es gibt keine allgemeinen Richtlinien dazu, in welchem Alter beim Ausbleiben von Pubertätsmerkmalen eine Abklärung erfolgen muss. Da eine Pubertas tarda dramatische Folgen für die geistige und soziale Entwicklung während der Adoleszenz haben kann, soll bei Mädchen eine erste Evaluation spätestens im Alter von 13 Jahren erfolgen. Bei starkem psychosozialem Druck, der wegen des Entwicklungsrückstands gegenüber Gleichaltrigen auf einem betroffenen Kind lasten kann, muss sie schon früher eingeleitet werden. Ein wichtiger Aspekt, der die Patientin und ihre Eltern oft beunruhigt, sind die möglichen Spätfolgen einer Pubertas tarda für die Fertilität. In der Regel sind bei hypogonadotropem Hypogonadismus die Aussichten auf eine erfolgreiche Schwangerschaft gut, wenn bei Kinderwunsch eine der Diagnose entsprechende adäquate Follikelreifungsinduktion durchgeführt wird. Dieser Beitrag soll dem Nichspezialisten eine Übersicht zu diesem Thema geben.

Schlüsselwörter

Hypothalamus Hypophyse Weibliche Infertilität Ovulationsinduktion Kallmann-Syndrom 

Delayed puberty due to hypogonadotropic hypogonadism

Evaluation, care and support, later fertility

Abstract

Puberty leads from childhood to adulthood. During fetal and neonatal life the hypothalamo-pituitary-gonadal axis is fully activated and then regresses in a stage of quiescence lasting up to puberty. Puberty then begins with reactivation of the gonadal axis. There are no general rules defining when clinical evaluation should be initiated in the total absence of signs of puberty . Because delayed puberty may have dramatic consequences for the mental and psychosocial development of adolescents, in girls a first evaluation should be started not later than at the age of 13 years; however, evaluation should be initiated earlier if psychosocial pressure is exerted on the child by the peer group because of delayed pubertal development. Another aspect that worries most patients and their parents is the potential long-term problem concerning fertility in adulthood. In general, the chances for a normal pregnancy are good if delayed puberty is due to hypogonadotropic hypogonadism and if in the case of the desire for a child a correct diagnosis is established and an adequate induction of follicular maturation is performed. This article gives a short overview for non-specialized gynecologists of the clinically important aspects of delayed puberty and the measures to be taken.

Keywords

Hypothalamus Pituitary gland Infertility, female Ovulation induction Kallmann syndrome 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

M. Birkhäuser gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Marshall WA, Tanner JM (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13–23CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Lee PA (1980) Normal ages of pubertal events among American males and females. J Adolesc Health Care 1:26–29CrossRefPubMedGoogle Scholar
  3. 3.
    Grumbach MM, Styne DM (1998) Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR (Hrsg) Williams textbook of endocrinology, 9. Aufl. WB Saunders, Philadelphia, S 1509–1625Google Scholar
  4. 4.
    Brämswig J, Dübbers A (2009) Disorders of pubertal development. Dtsch Arztebl Int 106(17):295–304PubMedPubMedCentralGoogle Scholar
  5. 5.
    Kahl HSRA, Schlaud M (2007) Sexuelle Reifung von Kindern und Jugendlichen in Deutschland. Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:677–685CrossRefPubMedGoogle Scholar
  6. 6.
    Reindollar RH, Tho SPT, McDonough PG (1989) Delayed puberty: an updated study of 326 patients. Trans Am Gynecol Obstet Soc 8:146–162Google Scholar
  7. 7.
    Tanner JM (1962) Growth at adolescence. Charles C Thomas, SpringfieldGoogle Scholar
  8. 8.
    Herman-Giddens ME, Slora EJ, Wasserman RC et al (1997) Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network. Pediatrics 99:505–512CrossRefPubMedGoogle Scholar
  9. 9.
    Kaplowitz PB, Oberfield SE, Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society (1999) Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Pediatrics 104:936–941CrossRefPubMedGoogle Scholar
  10. 10.
    Largo RH (1983) Pubertal development in Swiss girls. Helv Paediatr Acta 38(3):229–243PubMedGoogle Scholar
  11. 11.
    Kaplowitz P (2004) Clinical characteristics of 104 children referred for evaluation of precocious puberty. J Clin Endocrinol Metab 89:3644–3650CrossRefPubMedGoogle Scholar
  12. 12.
    Parent A‑S, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon J‑P (2003) The timing of normal puberty and the Age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 24(5):668–693CrossRefPubMedGoogle Scholar
  13. 13.
    Sedlmeyer IL, Palmert MR (2002) Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab 87:1613–1620CrossRefPubMedGoogle Scholar
  14. 14.
    Winter S, Ousidhoum A, McElreavey K, Raja Brauner R (2016) Constitutional delay of puberty: presentation and inheritance pattern in 48 familial cases. BMC Pediatr 16:37–44CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Bonjour J‑P (1998) Delayed puberty and peak bone mass. Eur J Endocrinol 139:257–259CrossRefPubMedGoogle Scholar
  16. 16.
    Reiter EO, Lee PA (2002) Delayed puberty. Adolesc Med 13(1):101–118PubMedGoogle Scholar
  17. 17.
    Reiter EO, Kaplan SL, Conte FA, Grumbach MM (1975) Resposivity of pituitary gonadotropins to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, precocious adrenarche and in patients treated with medroxyprogesterone acetate. Pediatr Res 9:111–115CrossRefPubMedGoogle Scholar
  18. 18.
    Gourmelen M, Pham-Huu-Trung MT, Girard F (1979) Transient partial GH deficiency in prepubertal children with delay of growth. Pediatr Res 13:221–224CrossRefPubMedGoogle Scholar
  19. 19.
    Lanes R, Bohorquez MDSL, Leal V, Hernandez G, Borges M, Hurtado E et al (1986) Growth hormone secretion in patients with constitutional delay of growth and pubertal development. J Pediatr 109:781–783CrossRefPubMedGoogle Scholar
  20. 20.
    Harrington J, Palmert MR (2012) Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests. J Clin Endocrinol Metab 97:3056–3067CrossRefPubMedGoogle Scholar
  21. 21.
    Dwyer AA, Phan-Hug F, Hauschild M, Elowe-Gruau E, Pitteloud N (2015) Hypogonadism in adolescence. Eur J Endocrinol 173:R15–R24CrossRefPubMedGoogle Scholar
  22. 22.
    Bierich JR (1989) Therapy with growth hormone—old and new indications. Horm Res 32:153–165CrossRefPubMedGoogle Scholar
  23. 23.
    Loche S, Cambiaso M, Setzu S et al (1994) Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature. J Pediatr 125:196–200CrossRefPubMedGoogle Scholar
  24. 24.
    Bernasconi S, Street ME, Volta C, Mazzardo G (1997) Final height in non-growth hormone deficient children treated with growth hormone. The Italian multicentre study group. Clin Endocrinol 47(3):261–266CrossRefGoogle Scholar
  25. 25.
    Kallmann FJ, Schönfeld WA, Barrera SE (1944) The genetic aspects of primary eunuchoidism. Am J Ment Defic 48:203–236Google Scholar
  26. 26.
    Quinton R, Duke VM, Robertson A et al (2001) Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol 55:163–174CrossRefGoogle Scholar
  27. 27.
    Brioude F, Bouligand J, Trabado S et al (2010) Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype–phenotype relationships. Eur J Endocrinol 162:835–851CrossRefPubMedGoogle Scholar
  28. 28.
    Lewkowitz-Shpuntoff HM, Hughes VA, Plummer L et al (2012) Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. J Clin Endocrinol Metab 97:E136–E144CrossRefPubMedGoogle Scholar
  29. 29.
    de Morsier G (1954) Etudes sur les dysraphies cranio-encephaliques. I. Agénésie des lobes olfactifs (Télencéphaloschizis latéral) et des commisures calleuse et antérieure (Télencéphaloschizis median). La dysplasie olfacto-génitale. Schweiz Arch Neurol Psychiatr 74:309–361Google Scholar
  30. 30.
    de San Maestre JA (1856) Teratologia: falta total de los nervios olfactorios con anosmia en un individuo en quien existía una atrofia congénita de los testículos y miembro viril. Siglo Med 3:211–221Google Scholar
  31. 31.
    Palmert MR, Dunkel L (2012) Clinical practice. Delayed puberty. N Engl J Med 366:443–453CrossRefPubMedGoogle Scholar
  32. 32.
    Mitchell AL, Dwyer A, Pitteloud N, Quinton R (2011) Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory. Trends Endocrinol Metab 22:249–258PubMedGoogle Scholar
  33. 33.
    Easter A, Treasure J, Micali N (2011) Fertility and prenatal attitudes towards pregnancy in women with eating disorders: results from the Avon Longitudinal Study of Parents. BJOG 118(12):1491–1498CrossRefPubMedGoogle Scholar
  34. 34.
    Bulik CM, Sullivan PF, Fear JL et al (1999) Fertility and reproduction in women with anorexia nervosa: a controlled study. J Clin Psychiatry 60(2):130–135CrossRefPubMedGoogle Scholar
  35. 35.
    Micali N, dos-Santos-Silva I, De Stavola B et al (2014) Fertility treatment, twin births, and unplanned pregnancies in women with eating disorders: findings from a population-based birth cohort. BJOG 121:408–416CrossRefPubMedGoogle Scholar
  36. 36.
    Park JK, Lee EJ, Kim SH (2012) Optimal surgical approaches for Rathke cleft cyst with consideration of endocrine function. Neurosurgery 70:250–257PubMedGoogle Scholar
  37. 37.
    Zada G, Laws ER (2010) Surgical management of craniopharyngiomas in the pediatric population. Horm Res Paediatr 74:62–66CrossRefPubMedGoogle Scholar
  38. 38.
    Jackman S, Diamond F (2013) Pituitary adenomas in childhood and adolescence. Pediatr Endocrinol Rev 10:450–459PubMedGoogle Scholar
  39. 39.
    Armstrong GT, Chow EJ, Sklar CA (2009) Alterations in pubertal timing following therapy for childhood malignancies. Endocr Dev 15:25–39CrossRefPubMedGoogle Scholar
  40. 40.
    Chandler WF, Barkan AL (2008) Treatment of pituitary tumors: a surgical perspective. Endocrinol Metab Clin North Am 37:51–66CrossRefPubMedGoogle Scholar
  41. 41.
    Colao A, Savastano S (2011) Medical treatment of prolactinomas. Nat Rev Endocrinol 7:267–278CrossRefPubMedGoogle Scholar
  42. 42.
    Lenz AM, Root AW (2012) Empty sella syndrome. Pediatr Endocrinol Rev 9(4):710–715PubMedGoogle Scholar
  43. 43.
    Leyendecker G, Wildt L (1982) Pulsatile treatment with gonadotropin-releasing hormone (Gn-RH). Geburtshilfe Frauenheilkd 42:689–699CrossRefPubMedGoogle Scholar
  44. 44.
    Birkhaeuser MH (1989) Pulsatile Therapie mit LH-RH. Arch Gynecol Obstet 246(Suppl 1):38–44CrossRefGoogle Scholar
  45. 45.
    Leyendecker G, Wildt L (1996) From physiology to clinics—29 years of experience with pulsatile GnRH. Eur J Obstet Gynecol Reprod Biol 65:S3–S12CrossRefPubMedGoogle Scholar
  46. 46.
    Hadžiomerović D, Wildt L (2006) Hypothalamische Ovarialinsuffizienz. Gynakol Endokrinol 4:27–32CrossRefGoogle Scholar
  47. 47.
    Lunenfeld B, Insler V (1995) In: Wallach EE, Zacur HE (Hrsg) Reproductive medicine and surgery. Mosby-Year Book, St. Louis, p. 617Google Scholar
  48. 48.
    Wildt L, Leyendecker G (1987) Induction of ovulation by the chronic administration of naltrexone in hypothalamic amerorrhea. J Clin Endocrinol Metabol 64:1334–1335CrossRefGoogle Scholar
  49. 49.
    Villanueva C, Argente J (2014) Pathology or normal variant: what constitutes a delay in puberty? Horm Res Paediatr 82:213–221CrossRefPubMedGoogle Scholar
  50. 50.
    Beier KM, Bosinski HAG, Loewit K (2005) Sexualmedizin, 2. Aufl. Urban & Fischer, Mosby-Year Book, München, Jena, St. Louis, S 617Google Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Gynäkologische Endokrinologie und ReproduktionsmedizinUniversität BernBaselSchweiz

Personalised recommendations